Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)

NCT: NCT07357428 · RECRUITING

NCT IDNCT07357428
StatusRECRUITING
Start Date2026-03-31
Completion2032-01

Brief Summary

The Connect-One Study is an early feasibility study to obtain preliminary device safety information for the Connexus Brain-Computer Interface (BCI). The Connexus BCI is intended to be used as: (1) an assistive communication device to decode imagined language correlates and speech for patients with impaired communication as a result of severe loss of voluntary motor control; and (2) to provide control of computer devices for individuals with severe loss of voluntary motor control of the upper extremity.

Frequently Asked Questions

What is Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)?

Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI) is a clinical trial registered under NCT07357428. Current status: RECRUITING.

What is the status of NCT07357428?

The current status of NCT07357428 (Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)) is: RECRUITING.

When did Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI) start?

Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI) started on 2026-03-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑